Search hospitals > British Columbia > VANCOUVER
University of British Columbia
Claim this profileVANCOUVER, British Columbia V6T 1Z4
Global Leader in Alzheimer's Disease
Global Leader in Depression
Conducts research for Multiple Sclerosis
Conducts research for Major Depressive Disorder
Conducts research for Stroke
213 reported clinical trials
18 medical researchers
Summary
University of British Columbia is a medical facility located in VANCOUVER, British Columbia. This center is recognized for care of Alzheimer's Disease, Depression, Multiple Sclerosis, Major Depressive Disorder, Stroke and other specialties. University of British Columbia is involved with conducting 213 clinical trials across 334 conditions. There are 18 research doctors associated with this hospital, such as Fidel Vila-Rodriguez, MD, PhD, Robin Hsiung, MD, Andrei Krassioukov, MD,PhD,FRCPC, and Raymond W Lam, MD.Area of expertise
1Alzheimer's Disease
Global LeaderPSEN2 positive
PSEN1 positive
APP positive
2Depression
Global LeaderTop PIs
Fidel Vila-Rodriguez, MD, PhDUniversity of British Columbia5 years of reported clinical research
Studies Depression
Studies Major Depressive Disorder
8 reported clinical trials
13 drugs studied
Robin Hsiung, MDUBC Hospital6 years of reported clinical research
Studies Alzheimer's Disease
Studies Dementia
8 reported clinical trials
13 drugs studied
Andrei Krassioukov, MD,PhD,FRCPCBlusson Spinal Cord Centre2 years of reported clinical research
Studies Spinal Cord Injury
Studies Neurogenic Bladder
5 reported clinical trials
9 drugs studied
Raymond W Lam, MDUniversity of British Columbia4 years of reported clinical research
Studies Depression
Studies Major Depressive Disorder
4 reported clinical trials
4 drugs studied
Clinical Trials running at University of British Columbia
Depression
Stroke
Major Depressive Disorder
Ischemic Stroke
Alzheimer's Disease
Opioid Use Disorder
Human Papillomavirus
Hemorrhagic Stroke
Cardiovascular Disease
Obstructive Sleep Apnea
Escitalopram + Brexpiprazole
for Depression
This is a study that will test a predictive biomarker algorithm based on results from a previous study. The goal of this study is to integrate clinical, imaging, EEG, and molecular data across 8 sites to predict treatment outcome for patients experiencing a major depressive episode (MDE).
Recruiting3 awards Phase 48 criteria
Aticaprant
for Depression
This trial is testing if adding aticaprant to current antidepressants is safe and well-tolerated in people with major depressive disorder. The goal is to see if it can help improve their treatment.
Recruiting2 awards Phase 316 criteria
Aticaprant
for Depression
This trial is testing aticaprant to see if it can help adults with major depressive disorder and anhedonia who haven't responded well to other antidepressants. Aticaprant works by blocking certain receptors in the brain to potentially improve depressive symptoms.
Recruiting1 award Phase 39 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at University of British Columbia?
University of British Columbia is a medical facility located in VANCOUVER, British Columbia. This center is recognized for care of Alzheimer's Disease, Depression, Multiple Sclerosis, Major Depressive Disorder, Stroke and other specialties. University of British Columbia is involved with conducting 213 clinical trials across 334 conditions. There are 18 research doctors associated with this hospital, such as Fidel Vila-Rodriguez, MD, PhD, Robin Hsiung, MD, Andrei Krassioukov, MD,PhD,FRCPC, and Raymond W Lam, MD.